Vaccine News and Research

Latest Vaccine News and Research

How might healthcare transform in the next 50 years?

A new study published in Futures highlighted key factors likely to influence the evolution of medicine over the next 50 years. These factors included wellness technologies, data-driven personalization, and climate change.

12 Jan 2023

The impact of prior SARS-CoV-2 infection and vaccination on Omicron infection

researchers explored the effects of prior SARS-CoV-2 infection and vaccination on SARS-CoV-2 Omicron infection.

12 Jan 2023

Recent progress in the understanding of neuraminidase-specific antibodies for the development of universal influenza vaccines

A recent study published in Viruses reviewed the characteristics of neuraminidase with emphasis on the development of NA-based universal influenza vaccines.

12 Jan 2023

Annual or biannual boosters greatly reduce the long-term risk of infection from endemic COVID-19

While COVID-19 boosters have been found to protect against infection, hospitalization, and severe illness, the waning of their protection has led to uncertainty about when it is most appropriate to get an additional booster shot.

11 Jan 2023

Study shows booster vaccinations against SARS-CoV-2 effective but protection wanes rapidly

A recent study posted to medRxiv* assessed the effectiveness of primary and booster vaccination against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the Netherlands.

11 Jan 2023

Bivalent boosters tested against all SARS-CoV-2 Omicron lineages

In a recent study posted to the bioRxiv* preprint server, researchers in the United States assessed the impact of the bivalent messenger ribonucleic acid (mRNA) severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine on the antibody-mediated neutralization of the SARS-CoV-2 Omicron lineages.

11 Jan 2023

Rethinking next generation of improved vaccines for mucosa-replicating viruses

Vaccines that provide long-lasting protection against influenza, coronaviruses and respiratory syncytial virus (RSV) have proved exceptionally difficult to develop.

11 Jan 2023

COVID-19 outcomes in Rituximab treated patients

A new report throws light on SARS-CoV-2 breakthrough infections in patients with certain joint diseases or musculoskeletal conditions who are on rituximab and compares the severity of COVID-19 outcomes in these patients whilst identifying potential risk factors for severe outcomes.

11 Jan 2023

Waning immunity hypothesis may explain mumps resurgence in the United States

Researchers investigated the putative mechanism(s) of vaccine failure underlying the resurgence of mumps in the United States (US).

11 Jan 2023

Researchers study congenital abnormalities after COVID-19 infection and vaccination

Researchers compared the significant congenital abnormalities observed after coronavirus disease 2019 (COVID-19) infection and vaccination.

11 Jan 2023

Real-world effectiveness of the bivalent vaccine for preventing COVID-19 hospitalizations in non-hospitalized subjects

Researchers investigated the efficacy of a booster dose of the bivalent mRNA COVID-19 vaccine in preventing severe outcomes during SARS-CoV-2 infections.

11 Jan 2023

New analysis improves the scientific community's understanding of COVID-19 immunity

A new analysis by Cedars-Sinai investigators is furthering the scientific community's understanding of COVID-19 immunity by showing that similar levels of COVID-19 antibodies are reached over an extended period of time in different population groups.

11 Jan 2023

FUJIFILM Irvine Scientific launches HEK293 Feed, specifically designed for viral vector production

FUJIFILM Irvine Scientific, Inc., a world leader in the development and manufacture of serum-free and chemically defined cell culture media for bioproduction and cell therapy manufacturing, today announced the launch of its BalanCD HEK293 Viral Feed.

11 Jan 2023

Dual COVID-19 and seasonal influenza vaccinations are associated with reduced infection rates

University of North Florida Brooks College of Health faculty recently published a study showing dual COVID-19 and seasonal influenza vaccinations are associated with reduced infection rates and can be an effective strategy to reduce the contagious respiratory disease burden during the winter.

10 Jan 2023

Spike protein mutations in Omicron subvariants increase their susceptibility to reductive cleavage of disulfide bonds

Researchers discovered that the spike protein of SARS-CoV-2 is susceptible to cleavage at the disulfide bonds, and the vulnerability to reductive cleavage varies across variants, with the Omicron variant family being highly susceptible to reduction.

10 Jan 2023

Hospitals’ use of volunteer staff runs risk of skirting labor laws, experts say

Most of the 30 volunteers who work at the 130-bed, for-profit East Cooper Medical Center spend their days assisting surgical patients — the scope of their duties extending far beyond those of candy stripers, baby cuddlers, and gift shop clerks.

10 Jan 2023

Astrea Bioseparations acquires Delta Precision Ltd, a leading manufacturer of chromatography columns for biomanufacturing

Astrea Bioseparations, a leading provider of high-quality bioseparation and purification technologies, announced today the acquisition of Delta Precision Ltd., a premier manufacturer of advanced chromatography columns for the biotechnology and pharmaceutical industries.

10 Jan 2023

Vaccine News and Research

Latest Vaccine News and Research

How might healthcare transform in the next 50 years?

The impact of prior SARS-CoV-2 infection and vaccination on Omicron infection

Recent progress in the understanding of neuraminidase-specific antibodies for the development of universal influenza vaccines

Annual or biannual boosters greatly reduce the long-term risk of infection from endemic COVID-19

Study shows booster vaccinations against SARS-CoV-2 effective but protection wanes rapidly

Bivalent boosters tested against all SARS-CoV-2 Omicron lineages

Rethinking next generation of improved vaccines for mucosa-replicating viruses

COVID-19 outcomes in Rituximab treated patients

Waning immunity hypothesis may explain mumps resurgence in the United States

Researchers study congenital abnormalities after COVID-19 infection and vaccination

Real-world effectiveness of the bivalent vaccine for preventing COVID-19 hospitalizations in non-hospitalized subjects

New analysis improves the scientific community's understanding of COVID-19 immunity

FUJIFILM Irvine Scientific launches HEK293 Feed, specifically designed for viral vector production

Dual COVID-19 and seasonal influenza vaccinations are associated with reduced infection rates

Spike protein mutations in Omicron subvariants increase their susceptibility to reductive cleavage of disulfide bonds

Hospitals’ use of volunteer staff runs risk of skirting labor laws, experts say

Astrea Bioseparations acquires Delta Precision Ltd, a leading manufacturer of chromatography columns for biomanufacturing

Vaccinating against toxin produced by E. coli may protect against malnutrition and stunting

Profound immune escape by SARS-CoV-2 XBB.1 even after 4 vaccine doses

New survey shows increase in COVID-19 vaccine acceptance across 23 countries in 2022

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Vaccine News and Research

Latest Vaccine News and Research

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Newsletters you may be interested in